Advertisement


Everett E. Vokes, MD, on Controversies in Stage IIIA Disease

2015 IASLC World Conference on Lung Cancer

Advertisement

Everett E. Vokes, MD, of the University of Chicago, summarizes expert views on treating stage IIIA disease: decision-making in selecting patients for surgery; multiple-modality choices; and using induction chemotherapy (Abstract ED10).



Related Videos

Lung Cancer

Naiyer A. Rizvi, MD, on Immune Checkpoint Inhibitors

Naiyer A. Rizvi, MD, of Columbia University, offers an update on immune checkpoint inhibitors in non–small cell lung cancer: what’s new and what’s next.

Lung Cancer

Karen Kelly, MD, on PD-1 Axis Inhibition and the Treatment of Advanced Disease

Karen Kelly, MD, of the University of California, Davis, summarizes three important papers on NSCLC: expression as a predictive biomarker; pembrolizumab, immune-mediated adverse ev...

Lung Cancer

Eric Lim, MD, on Increasing Incidence of Non-Smoking Lung Cancer

Eric Lim, MD, of the Royal Brompton and Harefield NHS Trust, discusses his findings on the nonspecific symptoms of never-smokers, which suggests that imaging could play a more impo...

Lung Cancer

Lorraine Cheryl Pelosof, MD, PhD, on Never-Smokers in NSCLC

Lorraine Cheryl Pelosof, MD, PhD, of UT Southwestern Medical Center, discusses her study findings, which demonstrate an increasing proportion of never-smokers among patients with n...

Lung Cancer

Vassiliki Papadimitrakopoulou, MD, on The Lung MAP Clinical Trial

Vassiliki Papadimitrakopoulou, MD, of MD Anderson Cancer Center, discusses the ways in which patients, investigators, and pharmaceutical companies are working together to accelerat...

Advertisement

Advertisement



Advertisement